Ventolin 20Ml Respirator Solution 5Mg

The management of asthma is advised to normally follow a stepwise programme, and patient response is advised to be monitored clinically and by lung function tests .
Increasing use of short-acting inhaled beta2 agonists to control symptoms indicates deterioration of asthma control. Under these conditions, the patient''''s therapy plan is advised to be reassessed. Sudden and progressive deterioration in asthma control is potentially lifethreatening and consideration is advised to be given to starting or increasing corticosteroid therapy. In patients considered at risk, daily peak flow monitoring may be instituted.
Patients is advised to be warned that if either the usual relief is diminished or the usual duration of action reduced, they is advised to not increase the dose or its frequency of administration, but is advised to seek medical advice.